Citations (142)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (14)
Yanmin Zhang, Mingliang Zhang, Yuchen Wang, Yuanrong Fan, Xingye Chen, Yan Yang, Yi Hua, Wuchen Xie, Tao Lu, Weifang Tang, Yadong Chen & Haichun Liu. (2020) Protein–ligand interaction-guided discovery of novel VEGFR-2 inhibitors. Journal of Biomolecular Structure and Dynamics 38:9, pages 2559-2574.
Read now
Read now
Maryam Saberi-Karimian, Niki Katsiki, Michele Caraglia, Mariarosaria Boccellino, Muhammed Majeed & Amirhossein Sahebkar. (2019) Vascular endothelial growth factor: An important molecular target of curcumin. Critical Reviews in Food Science and Nutrition 59:2, pages 299-312.
Read now
Read now
Xun Feng & Yang Chen. (2018) Drug delivery targets and systems for targeted treatment of rheumatoid arthritis. Journal of Drug Targeting 26:10, pages 845-857.
Read now
Read now
Zhaoting Li, Yijia Zhu, Chenchen Li, Ryan Trinh, Xueyan Ren, Fumou Sun, Youfu Wang, Pengzhao Shang, Tong Wang, Min Wang, Sherie L. Morrison & Juan Zhang. (2017) Anti-VEGFR2-interferon-α2 regulates the tumor microenvironment and exhibits potent antitumor efficacy against colorectal cancer. OncoImmunology 6:3.
Read now
Read now
N. Malecic & H. S. Young. (2016) Novel investigational vascular endothelial growth factor (VEGF) receptor antagonists for psoriasis. Expert Opinion on Investigational Drugs 25:4, pages 455-462.
Read now
Read now
Anja K Weidemann, Ania A Crawshaw, Emily Byrne & Helen S Young. (2013) Vascular endothelial growth factor inhibitors: investigational therapies for the treatment of psoriasis. Clinical, Cosmetic and Investigational Dermatology 6, pages 233-244.
Read now
Read now
Mohamed El-Khalawany, Dalia Shaaban, Maha Sultan & Fatma Abd AlSalam. (2012) Inhibition of angiogenesis as a new therapeutic target in the treatment of lepromatous leprosy. Clinical, Cosmetic and Investigational Dermatology 5, pages 1-6.
Read now
Read now
AA Crawshaw, CEM Griffiths & HS Young. (2012) Investigational VEGF antagonists for psoriasis. Expert Opinion on Investigational Drugs 21:1, pages 33-43.
Read now
Read now
Alex Yuan & Peter K. Kaiser. (2011) Emerging Therapies for the Treatment of Neovascular Age Related Macular Degeneration. Seminars in Ophthalmology 26:3, pages 149-155.
Read now
Read now
Marc Chamberlain. (2011) Evolving strategies: future treatment of glioblastoma. Expert Review of Neurotherapeutics 11:4, pages 519-532.
Read now
Read now
Michael S Gordon. (2011) Antiangiogenic therapies: is VEGF-A inhibition alone enough?. Expert Review of Anticancer Therapy 11:3, pages 485-496.
Read now
Read now
Zoltán Szekanecz, Timea Besenyei, György Paragh & Alisa E. Koch. (2009) Angiogenesis in rheumatoid arthritis. Autoimmunity 42:7, pages 563-573.
Read now
Read now
Costas Giaginis, Alexandra Margeli & Stamatios Theocharis. (2007) Peroxisome proliferator-activated receptor-γ ligands as investigational modulators of angiogenesis. Expert Opinion on Investigational Drugs 16:10, pages 1561-1572.
Read now
Read now
Piyush K Agarwal, Peter C Black, David J McConkey & Colin PN Dinney. (2007) Emerging drugs for targeted therapy of bladder cancer. Expert Opinion on Emerging Drugs 12:3, pages 435-448.
Read now
Read now
Articles from other publishers (128)
Hina Qayoom, Bader Alshehri, Burhan Ul Haq, Abdullah Almilaibary, Mustfa Alkhanani & Manzoor Ahmad Mir. (2023) Decoding the molecular mechanism of stypoldione against breast cancer through network pharmacology and experimental validation. Saudi Journal of Biological Sciences 30:12, pages 103848.
Crossref
Crossref
György Kerekes, Monika Czókolyová, Attila Hamar, Anita Pusztai, Gábor Tajti, Mónika Katkó, Edit Végh, Zsófia Pethő, Nóra Bodnár, Ágnes Horváth, Boglárka Soós, Szilvia Szamosi, Zsolt Hascsi, Mariann Harangi, Katalin Hodosi, György Panyi, Tamás Seres, Gabriella Szűcs & Zoltán Szekanecz. (2023) Effects of 1-year tofacitinib therapy on angiogenic biomarkers in rheumatoid arthritis. Rheumatology 62:SI3, pages SI304-SI312.
Crossref
Crossref
Hou Wanting, Zhong Jian, Xiao Chaoxin, Yi Cheng, Zhao Chengjian, Zhou Lin & Cao Dan. (2023) Using a zebrafish xenograft tumor model to compare the efficacy and safety of VEGFR-TKIs. Journal of Cancer Research and Clinical Oncology 149:9, pages 5975-5987.
Crossref
Crossref
Nancy Tripathi, Nivedita Bhardwaj, Sanjay Kumar & Shreyans K. Jain. (2023)
A machine learning‐based KNIME workflow to predict
VEGFR
‐2 inhibitors
. Chemical Biology & Drug Design 102:1, pages 38-50.
Crossref
Crossref
Katarzyna Masłowska, Patrycja Redkiewicz, Paweł Krzysztof Halik, Ewa Witkowska, Dagmara Tymecka, Rafał Walczak, Jarosław Choiński, Aleksandra Misicka & Ewa Gniazdowska. (2023) Scandium-44 Radiolabeled Peptide and Peptidomimetic Conjugates Targeting Neuropilin-1 Co-Receptor as Potential Tools for Cancer Diagnosis and Anti-Angiogenic Therapy. Biomedicines 11:2, pages 564.
Crossref
Crossref
Lu Dai, Juanjuan Luo, Meilan Feng, Maya Wang, Jiannan Zhang, Xiaoqian Cao, Xiaojun Yang & Juan Li. (2023) Nanoplastics exposure induces vascular malformation by interfering with the VEGFA/VEGFR pathway in zebrafish (Danio rerio). Chemosphere 312, pages 137360.
Crossref
Crossref
Abdul Rahman, Nippu Belur Ningegowda, Manjunatha Kammathalli Siddappa, Meghana Pargi, Honnenahally Malleshappa Kumaraswamy, Nayak Devappa Satyanarayan & Rajeshwara Achur. (2022)
Synthesis of Palladium‐Catalysed C−C Bond Forming 5‐Chloro Quinolines
via
Suzuki‐Miyaura Coupling; Anti‐Pancreatic Cancer Screening on PANC‐1 Cell Lines
. Chemistry & Biodiversity 20:1.
Crossref
Crossref
Junsha An, Cheng Peng, Xiaofang Xie & Fu Peng. (2022) New Advances in Targeted Therapy of HER2-Negative Breast Cancer. Frontiers in Oncology 12.
Crossref
Crossref
Feng Jiang, Xiaoling Liu, Xiaohui Wang, Jun Hu, Sha Chang & Xiaoli Cui. (2022) LncRNA FGD5-AS1 accelerates intracerebral hemorrhage injury in mice by adsorbing miR-6838-5p to target VEGFA. Brain Research 1776, pages 147751.
Crossref
Crossref
Nawaf A. Alsaif, Hazem A. Mahdy, Mohammed M. Alanazi, Ahmad J. Obaidullah, Hamad M. Alkahtani, Abdullah M. Al‐Hossaini, Abdulrahman A. Al‐Mehizi, Alaa Elwan & Mohammed S. Taghour. (2021) Targeting VEGFR‐2 by new quinoxaline derivatives: Design, synthesis, antiproliferative assay, apoptosis induction, and in silico studies. Archiv der Pharmazie 355:2, pages 2100359.
Crossref
Crossref
Katarzyna Masłowska, Ewa Witkowska, Dagmara Tymecka, Paweł Krzysztof Halik, Aleksandra Misicka & Ewa Gniazdowska. (2022) Synthesis, Physicochemical and Biological Study of Gallium-68- and Lutetium-177-Labeled VEGF-A165/NRP-1 Complex Inhibitors Based on Peptide A7R and Branched Peptidomimetic. Pharmaceutics 14:1, pages 100.
Crossref
Crossref
Dipayan Mondal, Sk. Abdul Amin, Md. Moinul, Kalpataru Das, Tarun Jha & Shovanlal Gayen. (2022) How the structural properties of the indole derivatives are important in kinase targeted drug design?: A case study on tyrosine kinase inhibitors. Bioorganic & Medicinal Chemistry 53, pages 116534.
Crossref
Crossref
M. Z. Saidov. (2021) Pathogenetic value of cell infiltrate in immunoinflammatory rheumatic diseases. Medical Immunology (Russia) 23:6, pages 1239-1270.
Crossref
Crossref
Kai Wang, Qinhua Chen, Nanxin Liu, Jie Zhang & Xiaoyan Pan. (2021) Recent advances in, and challenges of, anti-angiogenesis agents for tumor chemotherapy based on vascular normalization. Drug Discovery Today 26:11, pages 2743-2753.
Crossref
Crossref
Jiao Li, Hui Hou, Ling Zhou, Juanjuan Wang, Jiannan Liang, Junqin Li, Ruixia Hou, Xuping Niu, Guohua Yin, Xinhua Li & Kaiming Zhang. (2021) Increased angiogenesis and migration of dermal microvascular endothelial cells from patients with psoriasis. Experimental Dermatology 30:7, pages 973-981.
Crossref
Crossref
Ruo-Jun Man, Nasreen Jeelani, Chongchen Zhou & Yu-Shun Yang. (2021) Recent Progress in the Development of Quinoline Derivatives for the Exploitation of Anti-Cancer Agents. Anti-Cancer Agents in Medicinal Chemistry 21:7, pages 825-838.
Crossref
Crossref
Chen Junren, Xie Xiaofang, Zhang Huiqiong, Li Gangmin, Yin Yanpeng, Cao Xiaoyu, Gao Yuqing, Li Yanan, Zhang Yue, Peng Fu & Peng Cheng. (2021) Pharmacological Activities and Mechanisms of Hirudin and Its Derivatives - A Review. Frontiers in Pharmacology 12.
Crossref
Crossref
Margarida Ferreira-Silva, Catarina Faria-Silva, Pedro Viana Baptista, Eduarda Fernandes, Alexandra Ramos Fernandes & Maria Luísa Corvo. (2021) Liposomal Nanosystems in Rheumatoid Arthritis. Pharmaceutics 13:4, pages 454.
Crossref
Crossref
Katarzyna Masłowska, Paweł Krzysztof Halik, Dagmara Tymecka, Aleksandra Misicka & Ewa Gniazdowska. (2021) The Role of VEGF Receptors as Molecular Target in Nuclear Medicine for Cancer Diagnosis and Combination Therapy. Cancers 13:5, pages 1072.
Crossref
Crossref
Sandra Rother, Gloria Ruiz-Gómez, Kanagasabai Balamurugan, Linda Koehler, Karen M. Fiebig, Vanessa D. Galiazzo, Ute Hempel, Stephanie Moeller, Matthias Schnabelrauch, Johannes Waltenberger, M. Teresa Pisabarro, Dieter Scharnweber & Vera Hintze. (2020)
Hyaluronan/Collagen Hydrogels with Sulfated Glycosaminoglycans Maintain VEGF
165
Activity and Fine-Tune Endothelial Cell Response
. ACS Applied Bio Materials 4:1, pages 494-506.
Crossref
Crossref
Xiaoling Song, Yunping Hu, Yongsheng Li, Rong Shao, Fatao Liu & Yingbin Liu. (2020) Overview of current targeted therapy in gallbladder cancer. Signal Transduction and Targeted Therapy 5:1.
Crossref
Crossref
Yi Zhou, Min Han & Jianqing Gao. (2020) Prognosis and targeting of pre-metastatic niche. Journal of Controlled Release 325, pages 223-234.
Crossref
Crossref
Xinxin Pang, Yage Zhang, Zining Peng, Xiujie Shi, Jiarui Han & Yufeng Xing. (2020) Hirudin reduces nephropathy microangiopathy in STZ-induced diabetes rats by inhibiting endothelial cell migration and angiogenesis. Life Sciences 255, pages 117779.
Crossref
Crossref
Zhiqun Zhang, Ying Zhong, Xiaoxia Li, Xianmei Huang & Lizhong Du. (2020) Anti-placental growth factor antibody ameliorates hyperoxia-mediated impairment of lung development in neonatal rats. Brazilian Journal of Medical and Biological Research 53:2.
Crossref
Crossref
Linda Koehler, Gloria Ruiz-Gómez, Kanagasabai Balamurugan, Sandra Rother, Joanna Freyse, Stephanie Möller, Matthias Schnabelrauch, Sebastian Köhling, Snezana Djordjevic, Dieter Scharnweber, Jörg Rademann, M. Teresa Pisabarro & Vera Hintze. (2019) Dual Action of Sulfated Hyaluronan on Angiogenic Processes in Relation to Vascular Endothelial Growth Factor-A. Scientific Reports 9:1.
Crossref
Crossref
Shihao Chen, Jinge Xu, Qianhan Wei, Zeting Zhao, Xin Chen, Hengmi Cui & Yumei Zhang. (2019) VEGF/Flk1 Mechanism is Involved in Roxarsone Promotion of Rat Endothelial Cell Growth and B16F10 Xenograft Tumor Angiogenesis. Scientific Reports 9:1.
Crossref
Crossref
Jeong Yee, Woorim Kim, Byung Chul Chang, Jee Eun Chung, Kyung Eun Lee & Hye Sun Gwak. (2019)
Association between
VEGFA
gene polymorphisms and bleeding complications in patients maintaining therapeutic international normalized ratio
. Pharmacogenomics 20:9, pages 659-667.
Crossref
Crossref
Nan Zhu, Lijie Gu, Jieshuang Jia, Xuan Wang, Ling Wang, Man Yang & Weijie Yuan. (2018) Endothelin‐1 triggers human peritoneal mesothelial cells’ proliferation via ERK1/2‐Ets‐1 signaling pathway and contributes to endothelial cell angiogenesis. Journal of Cellular Biochemistry 120:3, pages 3539-3546.
Crossref
Crossref
Zhicheng Yang, Mingjie Wang, Ting Yan, Zhiyong Hu, Hui Zhang & Ruiping Liu. (2019) Association between vascular endothelial growth factor receptor 2 rs11941492 C/T polymorphism and Chinese Han patients in rheumatoid arthritis. Medicine 98:52, pages e18606.
Crossref
Crossref
Yanmin Zhang, Yadong Chen, Danfeng Zhang, Lu Wang, Tao Lu & Yu Jiao. (2017) Discovery of Novel Potent VEGFR-2 Inhibitors Exerting Significant Antiproliferative Activity against Cancer Cell Lines. Journal of Medicinal Chemistry 61:1, pages 140-157.
Crossref
Crossref
Sandra Rother, Sergey A. Samsonov, Stephanie Moeller, Matthias Schnabelrauch, Jörg Rademann, Joanna Blaszkiewicz, Sebastian Köhling, Johannes Waltenberger, M. Teresa Pisabarro, Dieter Scharnweber & Vera Hintze. (2017)
Sulfated Hyaluronan Alters Endothelial Cell Activation
in Vitro
by Controlling the Biological Activity of the Angiogenic Factors Vascular Endothelial Growth Factor-A and Tissue Inhibitor of Metalloproteinase-3
. ACS Applied Materials & Interfaces 9:11, pages 9539-9550.
Crossref
Crossref
Zoltán Szekanecz & Alisa E. Koch. 2017. Kelley and Firestein's Textbook of Rheumatology. Kelley and Firestein's Textbook of Rheumatology
384
395.e5
.
W.M. Thaiss, S. Kaufmann, C. Kloth, K. Nikolaou, H. B?sm?ller & M. Horger. (2016) VEGFR-2 expression in HCC, dysplastic and regenerative liver nodules, and correlation with pre-biopsy Dynamic Contrast Enhanced CT. European Journal of Radiology 85:11, pages 2036-2041.
Crossref
Crossref
Bin-rui Yang, Si-jia Hong, Simon Ming-Yuen Lee, Wei-hong Cong, Jian-bo Wan, Zhe-rui Zhang, Qing-wen Zhang, Yi Zhang, Yi-tao Wang & Zhi-xiu Lin. (2014) Pro-angiogenic activity of notoginsenoside R1 in human umbilical vein endothelial cells in vitro and in a chemical-induced blood vessel loss model of zebrafish in vivo. Chinese Journal of Integrative Medicine 22:6, pages 420-429.
Crossref
Crossref
Ge Liu, Shan Kuang, Shimei Wu, Weihua Jin & Chaomin Sun. (2016) A novel polysaccharide from Sargassum integerrimum induces apoptosis in A549 cells and prevents angiogensis in vitro and in vivo. Scientific Reports 6:1.
Crossref
Crossref
Yuan Gu, Christina Körbel, Claudia Scheuer, Anca Nenicu, Michael D. Menger & Matthias W. Laschke. (2015) Tubeimoside-1 suppresses tumor angiogenesis by stimulation of proteasomal VEGFR2 and Tie2 degradation in a non-small cell lung cancer xenograft model. Oncotarget 7:5, pages 5258-5272.
Crossref
Crossref
Gustav Steinemann, Christine Jacobsen, Mirjam Gerwing, Jessica Hauschild, Gunhild von Amsberg, Michael Höpfner, Bianca Nitzsche & Friedemann Honecker. (2016) Activity of nintedanib in germ cell tumors. Anti-Cancer Drugs 27:2, pages 89-98.
Crossref
Crossref
Hideyuki Mukai, Aiko Muramatsu, Rana Mashud, Koji Kubouchi, Sho Tsujimoto, Tsunaki Hongu, Yasunori Kanaho, Masanobu Tsubaki, Shozo Nishida, Go Shioi, Sally Danno, Mona Mehruba, Ryosuke Satoh & Reiko Sugiura. (2016) PKN3 is the major regulator of angiogenesis and tumor metastasis in mice. Scientific Reports 6:1.
Crossref
Crossref
Fan-Wei Peng, Ting-Ting Wu, Zi-Wei Ren, Jia-Yu Xue & Lei Shi. (2015) Hybrids from 4-anilinoquinazoline and hydroxamic acid as dual inhibitors of vascular endothelial growth factor receptor-2 and histone deacetylase. Bioorganic & Medicinal Chemistry Letters 25:22, pages 5137-5141.
Crossref
Crossref
Yanmin Zhang, Yu Jiao, Xiao Xiong, Haichun Liu, Ting Ran, Jinxing Xu, Shuai Lu, Anyang Xu, Jing Pan, Xin Qiao, Zhihao Shi, Tao Lu & Yadong Chen. (2015) Fragment virtual screening based on Bayesian categorization for discovering novel VEGFR-2 scaffolds. Molecular Diversity 19:4, pages 895-913.
Crossref
Crossref
Boh-Ram Kim, Seung Hee Seo, Mi Sun Park, Seung-Hoon Lee, Youngjoo Kwon & Seung Bae Rho. (2015) sMEK1 inhibits endothelial cell proliferation by attenuating VEGFR-2-dependent-Akt/eNOS/HIF-1α signaling pathways. Oncotarget 6:31, pages 31830-31843.
Crossref
Crossref
Silvia Salerno, Anna Maria Marini, Giacomo Fornaciari, Francesca Simorini, Concettina La Motta, Sabrina Taliani, Stefania Sartini, Federico Da Settimo, A?da Nelly Garc?a-Arg?ez, Ornella Gia, Sandro Cosconati, Ettore Novellino, Pilar D'Ocon, Anna Fioravanti, Paola Orlandi, Guido Bocci & Lisa Dalla Via. (2015) Investigation of new 2-aryl substituted Benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors targeting vascular endothelial growth factor receptor 2. European Journal of Medicinal Chemistry 103, pages 29-43.
Crossref
Crossref
Paul C. Lobben, Evan Barlow, James S. Bergum, Alan Braem, Shih-Ying Chang, Frank Gibson, Nathaniel Kopp, Chiajen Lai, Thomas L. LaPorte, David K. Leahy, Jale Müslehiddinoğlu, Fernando Quiroz, Dimitri Skliar, Lori Spangler, Sushil Srivastava, Daniel Wasser, John Wasylyk, Robert Wethman & Zhongmin Xu. (2014) Control Strategy for the Manufacture of Brivanib Alaninate, a Novel Pyrrolotriazine VEGFR/FGFR Inhibitor. Organic Process Research & Development 19:8, pages 900-907.
Crossref
Crossref
Madelane Teran & Matthew A. Nugent. (2015) Synergistic Binding of Vascular Endothelial Growth Factor-A and Its Receptors to Heparin Selectively Modulates Complex Affinity. Journal of Biological Chemistry 290:26, pages 16451-16462.
Crossref
Crossref
Ya‐Hui DengDan XuYe‐Xiang SuYi‐Juan ChengYan‐Li Yang, Xiu‐Yun Wang, Juan Zhang, Qi‐Dong You & Li‐Ping Sun. (2015)
Synthesis and Biological Evaluation of Novel Oxazolo[5,4‐
d
]pyrimidines as Potent VEGFR‐2 Inhibitors
. Chemistry & Biodiversity 12:4, pages 528-537.
Crossref
Crossref
Izuagie Attairu Ikhapoh, Christopher J. Pelham & Devendra K. Agrawal. (2015) Sry-type HMG box 18 contributes to the differentiation of bone marrow-derived mesenchymal stem cells to endothelial cells. Differentiation 89:3-4, pages 87-96.
Crossref
Crossref
PEIWU LI, WANGSHENG CHEN, YINGZHEN WANG, XU FU, KUNMING WEN, JIANG QIAN, CHUN HUANG & ZHONGXUE FU. (2015) Effects of ephrinB2 gene siRNA on the biological behavior of human colorectal cancer cells. Oncology Reports 33:2, pages 758-766.
Crossref
Crossref
Zoltan Szekanecz, Emese Balogh & Alisa E. Koch. 2015. Rheumatology. Rheumatology
764
767
.
Wei Xie, Daojuan Li, Juan Zhang, Zhike Li, Desmond Omane Acheampong, Yuan He, Youfu Wang, Zhiguo Chen & Min Wang. (2014) Generation and characterization of a novel human IgG1 antibody against vascular endothelial growth factor receptor 2. Cancer Immunology, Immunotherapy 63:9, pages 877-888.
Crossref
Crossref
Feng Zhang, Zili Zhang, Li Chen, Desong Kong, Xiaoping Zhang, Chunfeng Lu, Yin Lu & Shizhong Zheng. (2014) Curcumin attenuates angiogenesis in liver fibrosis and inhibits angiogenic properties of hepatic stellate cells. Journal of Cellular and Molecular Medicine 18:7, pages 1392-1406.
Crossref
Crossref
Jaan A. Pesti, Thomas LaPorte, John E. Thornton, Lori Spangler, Frederic Buono, Gerard Crispino, Frank Gibson, Paul Lobben & Christos G. Papaioannou. (2013) Commercial Synthesis of a Pyrrolotriazine–Fluoroindole Intermediate to Brivanib Alaninate: Process Development Directed toward Impurity Control. Organic Process Research & Development 18:1, pages 89-102.
Crossref
Crossref
Xiaodong Wang & Stephen Frye. 2014.
301
314
.
Yanmin Zhang, Shangyan Yang, Yu Jiao, Haichun Liu, Haoliang Yuan, Shuai Lu, Ting Ran, Sihui Yao, Zhipeng Ke, Jinxing Xu, Xiao Xiong, Yadong Chen & Tao Lu. (2013) An Integrated Virtual Screening Approach for VEGFR-2 Inhibitors. Journal of Chemical Information and Modeling 53:12, pages 3163-3177.
Crossref
Crossref
Anne S. Tsao, Vassiliki Papadimitrakopoulou & Roy S. Herbst. 2015. Molecular Oncology. Molecular Oncology
872
883
.
Kazuhisa Ishimoto, Yasuhiro Sawai, Naohiro Fukuda, Toshiaki Nagata & Tomomi Ikemoto. (2013) Convergent and streamlined synthesis of 6-etherified imidazo[1,2-b]pyridazine-2-amine derivatives possessing VEGFR-2 kinase inhibitory activity. Tetrahedron 69:40, pages 8564-8571.
Crossref
Crossref
Youzhi Xu, Hongjun Lin, Nana Meng, Wenjie Lu, Guobo Li, Yuanyuan Han, Xiaoyun Dai, Yong Xia, Xiangrong Song, Shengyong Yang, Yuquan Wei, Luoting Yu & Yinglan Zhao. (2013) YL529, a novel, orally available multikinase inhibitor, potently inhibits angiogenesis and tumour growth in preclinical models. British Journal of Pharmacology 169:8, pages 1766-1780.
Crossref
Crossref
Zhiyu Wang, Neng Wang, Shouwei Han, Dongmei Wang, Suilin Mo, Linzhong Yu, Hui Huang, Kamchuen Tsui, Jiangang Shen & Jianping Chen. (2013) Dietary Compound Isoliquiritigenin Inhibits Breast Cancer Neoangiogenesis via VEGF/VEGFR-2 Signaling Pathway. PLoS ONE 8:7, pages e68566.
Crossref
Crossref
James P. LandryYiyan FeiXiangdong ZhuYaohuang KeGuoliang YuPierre Lee. (2013) Discovering Small Molecule Ligands of Vascular Endothelial Growth Factor That Block VEGF–KDR Binding Using Label-Free Microarray-Based Assays. ASSAY and Drug Development Technologies 11:5, pages 326-332.
Crossref
Crossref
Evangelia Pardali, Rinesh Godfrey & Johannes Waltenberger. 2013. Tumor Angiogenesis Regulators. Tumor Angiogenesis Regulators
1
36
.
Dylan T. Jones, Tanguy Lechertier, Louise E. Reynolds, Richard Mitter, Stephen D. Robinson, Catherine B. Kirn-Safran & Kairbaan M. Hodivala-Dilke. (2013) Endogenous ribosomal protein L29 (RPL29): a newly identified regulator of angiogenesis in mice. Disease Models & Mechanisms 6:1, pages 115-124.
Crossref
Crossref
Qingqing Meng & Zheng Li. (2013) Molecular Imaging Probes for Diagnosis and Therapy Evaluation of Breast Cancer. International Journal of Biomedical Imaging 2013, pages 1-14.
Crossref
Crossref
N Kanagawa, T Yanagawa, T Nakagawa, N Okada & S Nakagawa. (2012) Tumor vessel-injuring ability improves antitumor effect of cytotoxic T lymphocytes in adoptive immunotherapy. Cancer Gene Therapy 20:1, pages 57-64.
Crossref
Crossref
Zoltan Szekanecz & Alisa E. Koch. 2013. Kelley's Textbook of Rheumatology. Kelley's Textbook of Rheumatology
358
368.e5
.
Eun-Kyung Shin & Jin-Kyung Kim. (2012) Indirubin derivative E804 inhibits angiogenesis. BMC Cancer 12:1.
Crossref
Crossref
Kenji Sakoda, Yumiko Nakajima & Kazuyuki Noguchi. (2012) Enamel matrix derivative induces production of vascular endothelial cell growth factor in human gingival fibroblasts. European Journal of Oral Sciences 120:6, pages 513-519.
Crossref
Crossref
Qian Lu, Shuai Lu, Xinghua Gao, Yubin Luo, Bei Tong, Zhifeng Wei, Tao Lu, Yufeng Xia, Guixin Chou, Zhengtao Wang & Yue Dai. (2012) Norisoboldine, an alkaloid compound isolated from Radix Linderae, inhibits synovial angiogenesis in adjuvant-induced arthritis rats by moderating Notch1 pathway-related endothelial tip cell phenotype. Experimental Biology and Medicine 237:8, pages 919-932.
Crossref
Crossref
I. Flisiak, P. Zaniewski, M. Rogalska-Taranta & B. Chodynicka. (2012) Effect of psoriasis therapy on VEGF and its soluble receptors serum concentrations. Journal of the European Academy of Dermatology and Venereology 26:3, pages 302-307.
Crossref
Crossref
Piyush B Madhamshettiwar, Stefan R Maetschke, Melissa J Davis, Antonio Reverter & Mark A Ragan. (2012) Gene regulatory network inference: evaluation and application to ovarian cancer allows the prioritization of drug targets. Genome Medicine 4:5, pages 41.
Crossref
Crossref
Jiachang Gong, Jinping Gan & Ramaswamy A. Iyer. (2012) Identification of the Oxidative and Conjugative Enzymes Involved in the Biotransformation of Brivanib. Drug Metabolism and Disposition 40:1, pages 219-226.
Crossref
Crossref
Pascal Bonnet, Daniel Mucs & Richard A. Bryce. (2012) Targeting the inactive conformation of protein kinases: computational screening based on ligand conformation. Med. Chem. Commun. 3:4, pages 434-440.
Crossref
Crossref
Cristina Suarez & Brian I. Rini. 2012. Renal Cell Carcinoma. Renal Cell Carcinoma
115
133
.
Shayne Cox GadZoltán Szekanecz & Alisa E. Koch. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia.
Su-Jin CheongChang-Moon LeeDooRye JangEun-Mi KimMin-Hee JeongTai-Boong UhmWeon-Sup LeeHwan-Jeong JeongDong Wook KimSeok Tae LimMyung-Hee Sohn. (2011) Effect of Molecular Imaging on Validation of Developed Anti-hVEGFR2 Therapeutic Antibody. Cancer Biotherapy and Radiopharmaceuticals 26:6, pages 745-751.
Crossref
Crossref
Jianfei Huang, Huijun Zhu, Xudong Wang, Qi Tang, Hua Huang, Kerong Wu, Jin Zhu, Zhenqing Feng & Gongshen Shi. (2011) The patterns and expression of KDR in normal tissues of human internal organs. Journal of Molecular Histology 42:6, pages 597-603.
Crossref
Crossref
Jin-Sun Kong, Seung-Ah Yoo, Jong-Hoon Kang, Wooree Ko, Sangmin Jeon, Chi-Bom Chae, Chul-Soo Cho & Wan-Uk Kim. (2011) Suppression of neovascularization and experimental arthritis by D-form of anti-flt-1 peptide conjugated with mini-PEG?. Angiogenesis 14:4, pages 431-442.
Crossref
Crossref
Michael T. Cheeseman, Hayley E. Tyrer, Debbie Williams, Tertius A. Hough, Paras Pathak, Maria R. Romero, Helen Hilton, Sulzhan Bali, Andrew Parker, Lucie Vizor, Tom Purnell, Kate Vowell, Sara Wells, Mahmood F. Bhutta, Paul K. Potter & Steve D. M. Brown. (2011) HIF–VEGF Pathways Are Critical for Chronic Otitis Media in Junbo and Jeff Mouse Mutants. PLoS Genetics 7:10, pages e1002336.
Crossref
Crossref
Scott B. Tran, Michael W. Lago, Yuan Tian, Sharon X. Gong, Indu Batra, Alban J. Allentoff, Brad D. Maxwell, Samuel J. Bonacorsi, Marc Ogan, J. Kent Rinehart & Balu Balasubramanian. (2011) The 14C, 13C, and 15N syntheses of a potent VEGFR-2 kinase inhibitor, Brivanib, and its prodrug, Brivanib Alaninate. Journal of Labelled Compounds and Radiopharmaceuticals 54:6, pages 324-331.
Crossref
Crossref
Jianfei Huang, Xialing Zhang, Qi Tang, Feng Zhang, Yuhua Li, Zhenqing Feng & Jin Zhu. (2011) Prognostic significance and potential therapeutic target of VEGFR2 in hepatocellular carcinoma. Journal of Clinical Pathology 64:4, pages 343-348.
Crossref
Crossref
Sònia Tugues, Sina Koch, Laura Gualandi, Xiujuan Li & Lena Claesson-Welsh. (2011) Vascular endothelial growth factors and receptors: Anti-angiogenic therapy in the treatment of cancer. Molecular Aspects of Medicine 32:2, pages 88-111.
Crossref
Crossref
Takahiro Honda, Hironori Nagahara, Hiroyuki Mogi, Masakazu Ban & Hiroyuki Aono. (2011) KDR inhibitor with the intramolecular non-bonded interaction: Conformation–activity relationships of novel indole-3-carboxamide derivatives. Bioorganic & Medicinal Chemistry Letters 21:6, pages 1782-1785.
Crossref
Crossref
Mi-Kyoung Ha, Young Hoon Song, Soo-Jin Jeong, Hyo-Jung Lee, Ji Hoon Jung, Bonglee Kim, Hyo Sook Song, Jeong-Eun Huh & Sung-Hoon Kim. (2011) Emodin Inhibits Proinflammatory Responses and Inactivates Histone Deacetylase 1 in Hypoxic Rheumatoid Synoviocytes. Biological and Pharmaceutical Bulletin 34:9, pages 1432-1437.
Crossref
Crossref
Zhi-Xing Cao, Ren-Lin Zheng, Hong-Jun Lin, Shi-Dong Luo, Yan Zhou, You-Zhi Xu, Xiu-Xiu Zeng, Zhao Wang, Li-Na Zhou, Yong-qiu Mao, Li Yang, Yu-Quan Wei, Luo-Ting Yu, Sheng-Yong Yang & Ying-Lan Zhao. (2011) SKLB610: A Novel Potential Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases Inhibits Angiogenesis and Tumor Growth <i>in Vivo</i>. Cellular Physiology and Biochemistry 27:5, pages 565-574.
Crossref
Crossref
Zoltán Szekanecz & Alisa E. Koch. 2011. Rheumatology. Rheumatology
905
909.e1
.
Iwona Flisiak, Przemysław Zaniewski, Magdalena Rogalska, Hanna Myśliwiec, Jerzy Jaroszewicz & Bożena Chodynicka. (2010) Effect of psoriasis activity on VEGF and its soluble receptors concentrations in serum and plaque scales. Cytokine 52:3, pages 225-229.
Crossref
Crossref
Yalda Shokoohinia, Seyed-Ebrahim Sajjadi, Behzad Zolfaghari, Giuseppina Chianese, Giovanni Appendino & Orazio Taglialatela-Scafati. (2010) Diterpenoid (poly)esters and a ring A-seco-phorboid from the aerial parts of Euphorbia macroclada Boiss. Fitoterapia 81:7, pages 884-890.
Crossref
Crossref
Chandramu Chetty, Sajani S. Lakka, Praveen Bhoopathi & Jasti S. Rao. (2010)
MMP‐2 alters VEGF expression
via
αVβ3 integrin‐mediated PI3K/AKT signaling in A549 lung cancer cells
. International Journal of Cancer 127:5, pages 1081-1095.
Crossref
Crossref
Nam Hee Kim, Ngoc Bich Pham, Ronald J. Quinn & Ho Jeong Kwon. (2010) R-(–)-β-O-methylsynephrine, a natural product, inhibits VEGF-induced angiogenesis in vitro and in vivo. Biochemical and Biophysical Research Communications 399:1, pages 20-23.
Crossref
Crossref
Ji Zhang & Jie Jack Li. 2010. Modern Drug Synthesis. Modern Drug Synthesis
111
122
.
Chun-Hsu Pan, I-Chun Hsieh, Fon-Chang Liu, Wen-Tsong Hsieh, Ming-Jyh Sheu, Ayano Koizumi & Chieh-Hsi Wu. (2010) Effects of a Chinese Herbal Health Formula, “Gan-Lu-Yin”, on Angiogenesis. Journal of Agricultural and Food Chemistry 58:13, pages 7685-7692.
Crossref
Crossref
Zoltán Szekanecz & Alisa E Koch. (2010) VEGF as an activity marker in rheumatoid arthritis. International Journal of Clinical Rheumatology 5:3, pages 287-289.
Crossref
Crossref
Zoltán Szekanecz, Timea Besenyei, Ágnes Szentpétery & Alisa E Koch. (2010) Angiogenesis and vasculogenesis in rheumatoid arthritis. Current Opinion in Rheumatology 22:3, pages 299-306.
Crossref
Crossref
Jihong Zhang, Yingchun Zheng, Yunxiu Wang & Haixia Tong. (2010) The Studies on the Correlation for Gene Expression of Tyrosine-kinase Receptors and Vascular Endothelial Growth Factor in Human Neuroblastomas. Journal of Pediatric Hematology/Oncology 32:3, pages 180-184.
Crossref
Crossref
Anthony M. Fletcher, Carla L. Bregman, Jochen Woicke, Theodora W. Salcedo, Robert H. Zidell, Helen E. Janke, Hengsheng Fang, William J. Janusz, Gene E. Schulze & Mark G. Mense. (2010) Incisor Degeneration in Rats Induced by Vascular Endothelial Growth Factor/Fibroblast Growth Factor Receptor Tyrosine Kinase Inhibition. Toxicologic Pathology 38:2, pages 267-279.
Crossref
Crossref
Frédéric Gaudette, Stéphane Raeppel, Hannah Nguyen, Normand Beaulieu, Carole Beaulieu, Isabelle Dupont, A. Robert Macleod, Jeffrey M. Besterman & Arkadii Vaisburg. (2010) Identification of potent and selective VEGFR receptor tyrosine kinase inhibitors having new amide isostere headgroups. Bioorganic & Medicinal Chemistry Letters 20:3, pages 848-852.
Crossref
Crossref
Athanasios Papakyriakou, MariaâE. Katsarou, Maria Belimezi, Michael Karpusas & Dionisios Vourloumis. (2010) Discovery of Potent Vascular Endothelial Growth Factor Receptor-2 Inhibitors. ChemMedChem 5:1, pages 118-129.
Crossref
Crossref
Shu Guang Zuo, Yan Chen, Zhi Ping Wu, Xin Liu, Chun Liu, Yong Chun Zhou, Cui Ling Wu, Cong Guo Jin, Yu Lan Gu, Jia Li, Xiao Qun Chen, Yong Li, Hui Ping Wei, Li Hua Li & Xi Cai Wang. (2010) Orally Administered DNA Vaccine Delivery by Attenuated Salmonella typhimurium Targeting Fetal Liver Kinase 1 Inhibits Murine Lewis Lung Carcinoma Growth and Metastasis. Biological & Pharmaceutical Bulletin 33:2, pages 174-182.
Crossref
Crossref
Zoltán Szekanecz, Timea Besenyei, György Paragh & Alisa E. Koch. (2010) Actualités sur l’angiogenèse synoviale. Revue du Rhumatisme 77:1, pages 14-20.
Crossref
Crossref
Zoltán Szekanecz, Timea Besenyei, György Paragh & Alisa E. Koch. (2010) New insights in synovial angiogenesis. Joint Bone Spine 77:1, pages 13-19.
Crossref
Crossref
Cristina Suárez, Rafael Morales, Eva Muñoz, Jordi Rodón, Claudia M. Valverde & Joan Carles. (2010) Molecular basis for the treatment of renal cell carcinoma. Clinical and Translational Oncology 12:1, pages 15-21.
Crossref
Crossref
Jianfei Huang, Yang Tan, Qi Tang, Xinjian Liu, Xiaohong Guan, Zhenqing Feng & Jin Zhu. (2010) A high-affinity human/mouse cross-reactive monoclonal antibody, specific for VEGFR-2 linear and conformational epitopes. Cytotechnology 62:1, pages 61-71.
Crossref
Crossref
Yong Li & Paul J. Cozzi. (2009) Angiogenesis as a strategic target for prostate cancer therapy. Medicinal Research Reviews 30:1, pages 23-66.
Crossref
Crossref
Oscar Saavedra, Stephen Claridge, Lijie Zhan, Franck Raeppel, Marie-Claude Granger, Stéphane Raeppel, Michael Mannion, Frédéric Gaudette, Nancy Zhou, Ljubomir Isakovic, Naomy Bernstein, Robert Déziel, Hannah Nguyen, Normand Beaulieu, Carole Beaulieu, Isabelle Dupont, James Wang, A. Robert Macleod, Jeffrey M. Besterman & Arkadii Vaisburg. (2009) N3-Arylmalonamides: A new series of thieno[3,2-b]pyridine based inhibitors of c-Met and VEGFR2 tyrosine kinases. Bioorganic & Medicinal Chemistry Letters 19:24, pages 6836-6839.
Crossref
Crossref
Michael Mannion, Stéphane Raeppel, Stephen Claridge, Nancy Zhou, Oscar Saavedra, Ljubomir Isakovic, Lijie Zhan, Frédéric Gaudette, Franck Raeppel, Robert Déziel, Normand Beaulieu, Hannah Nguyen, Ian Chute, Carole Beaulieu, Isabelle Dupont, Marie-France Robert, Sylvain Lefebvre, Marja Dubay, Jubrail Rahil, James Wang, Hélène Ste-Croix, A. Robert Macleod, Jeffrey M. Besterman & Arkadii Vaisburg. (2009) N-(4-(6,7-Disubstituted-quinolin-4-yloxy)-3-fluorophenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides: A novel series of dual c-Met/VEGFR2 receptor tyrosine kinase inhibitors. Bioorganic & Medicinal Chemistry Letters 19:23, pages 6552-6556.
Crossref
Crossref
S. Percy Ivy, Jeannette Y. Wick & Bennett M. Kaufman. (2009) An overview of small-molecule inhibitors of VEGFR signaling. Nature Reviews Clinical Oncology 6:10, pages 569-579.
Crossref
Crossref
Zoltán Szekanecz & Alisa E. Koch. (2009) Angiogenesis and its targeting in rheumatoid arthritis. Vascular Pharmacology 51:1, pages 1-7.
Crossref
Crossref
Alexander S. Kiselyov, Eugene L. Piatnitski Chekler, Natalia B. Chernisheva, Lev K. Salamandra & Victor V. Semenov. (2009) Design and chemical synthesis of [1,2,4]triazol[1,5-c]pyrimidin-5-yl amines, a novel class of VEGFR-2 kinase inhibitors. Tetrahedron Letters 50:27, pages 3809-3812.
Crossref
Crossref
Zhe-xue Qin, Qian-wei Li, Guang-yuan Liu, Chao-xue Luo, Gan-feng Xie, Lei Zheng & Ding-de Huang. (2009) Imaging targeted at tumor with 188Re-labeled VEGF189 exon 6-encoded peptide and effects of the transfecting truncated KDR gene in tumor-bearing nude mice. Nuclear Medicine and Biology 36:5, pages 535-543.
Crossref
Crossref
Wolfram C.M. Dempke & Volker Heinemann. (2009) Resistance to EGF-R (erbB-1) and VEGF-R modulating agents. European Journal of Cancer 45:7, pages 1117-1128.
Crossref
Crossref
Si-Jia Hong, Jian-Bo Wan, Yi Zhang, Guang Hu, Hui-Chao Lin, Sai Wang Seto, Yiu-Wa Kwan, Zhi-Xiu Lin, Yi-Tao Wang & Simon Ming-Yuen Lee. (2009)
Angiogenic effect of saponin extract from
Panax notoginseng
on HUVECs
in vitro
and zebrafish
in vivo
. Phytotherapy Research 23:5, pages 677-686.
Crossref
Crossref
Stéphane Raeppel, Stephen Claridge, Oscar Saavedra, Frédéric Gaudette, Lijie Zhan, Michael Mannion, Nancy Zhou, Franck Raeppel, Marie-Claude Granger, Ljubomir Isakovic, Robert Déziel, Hannah Nguyen, Normand Beaulieu, Carole Beaulieu, Isabelle Dupont, Marie-France Robert, Sylvain Lefebvre, Marja Dubay, Jubrail Rahil, James Wang, Hélène Ste-Croix, A. Robert Macleod, Jeffrey Besterman & Arkadii Vaisburg. (2009) N-(3-fluoro-4-(2-arylthieno[3,2-b]pyridin-7-yloxy)phenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides: A novel series of dual c-Met/VEGFR2 receptor tyrosine kinase inhibitors. Bioorganic & Medicinal Chemistry Letters 19:5, pages 1323-1328.
Crossref
Crossref
Alexander S. Kiselyov, Marina Semenova & Victor V. Semenov. (2009) (1,2,3-Triazol-4-yl)benzenamines: Synthesis and activity against VEGF receptors 1 and 2. Bioorganic & Medicinal Chemistry Letters 19:5, pages 1344-1348.
Crossref
Crossref
Alexander S. Kiselyov, Marina Semenova & Victor V. Semenov. (2009) 3,4-Disubstituted isothiazoles: Novel potent inhibitors of VEGF receptors 1 and 2. Bioorganic & Medicinal Chemistry Letters 19:4, pages 1195-1198.
Crossref
Crossref
Zoltán Szekanecz & Alisa E. Koch. 2009. Rheumatoid Arthritis. Rheumatoid Arthritis
168
179
.
Bo Hu & Shi-Yuan Cheng. 2009. CNS Cancer. CNS Cancer
461
506
.
Marie C. DeFrances. 2010. Hepatocellular Carcinoma. Hepatocellular Carcinoma
109
130
.
Suzanne A Eccles, William Court, Lisa Patterson & Sharon Sanderson. 2009. Angiogenesis Protocols. Angiogenesis Protocols
159
181
.
Stephen Claridge, Franck Raeppel, Marie-Claude Granger, Naomy Bernstein, Oscar Saavedra, Lijie Zhan, David Llewellyn, Amal Wahhab, Robert Deziel, Jubrail Rahil, Normand Beaulieu, Hannah Nguyen, Isabelle Dupont, Annie Barsalou, Carole Beaulieu, Ian Chute, Serge Gravel, Marie-France Robert, Sylvain Lefebvre, Marja Dubay, Roussen Pascal, Jeff Gillespie, Zhiyun Jin, James Wang, Jeffrey M. Besterman, A. Robert MacLeod & Arkadii Vaisburg. (2008) Discovery of a novel and potent series of thieno[3,2-b]pyridine-based inhibitors of c-Met and VEGFR2 tyrosine kinases. Bioorganic & Medicinal Chemistry Letters 18:9, pages 2793-2798.
Crossref
Crossref
Zhen-wei Cai, Yongzheng Zhang, Robert M. Borzilleri, Ligang Qian, Stephanie Barbosa, Donna Wei, Xiaoping Zheng, Lawrence Wu, Junying Fan, Zhongping Shi, Barri S. Wautlet, Steve Mortillo, Robert JeyaseelanSr.Sr., Daniel W. Kukral, Amrita Kamath, Punit Marathe, Celia D’Arienzo, George Derbin, Joel C. Barrish, Jeffrey A. Robl, John T. Hunt, Louis J. Lombardo, Joseph Fargnoli & Rajeev S. Bhide. (2008)
Discovery of Brivanib Alaninate ((
S
)-((
R
)-1-(4-(4-Fluoro-2-methyl-1
H
-indol-5-yloxy)-5-methylpyrrolo[2,1-
f
][1,2,4]triazin-6-yloxy)propan-2-yl)2-aminopropanoate), A Novel Prodrug of Dual Vascular Endothelial Growth Factor Receptor-2 and Fibroblast Growth Factor Receptor-1 Kinase Inhibitor (BMS-540215)
. Journal of Medicinal Chemistry 51:6, pages 1976-1980.
Crossref
Crossref
Seung Joon KimJung Mi LeeJin Sook KimJi Young KangSang Hak LeeSeok Chan KimSook Young LeeChi Hong KimJoong Hyun AhnSoon Seog KwonYoung Kyoon KimKwan Hyoung KimHwa Sik MoonJeong Sup SongSung Hak ParkSeok Hwan MoonYeong Pil Wang. (2008) Prognostic Value of Vascular Endothelial Growth Factor (VEGF) and Basic Fibroblast Growth Factor (bFGF) Expression in Resected Non-small Cell Lung Cancer. Tuberculosis and Respiratory Diseases 64:3, pages 200.
Crossref
Crossref
Costas Giaginis, Anna Tsantili-Kakoulidou & Stamatios Theocharis. (2008)
Peroxisome Proliferator-Activated Receptor-
Ligands: Potential Pharmacological Agents for Targeting the Angiogenesis Signaling Cascade in Cancer
. PPAR Research 2008, pages 1-12.
Crossref
Crossref
Seung-Ah Yoo, Seung-Ki Kwok & Wan-Uk Kim. (2008) Proinflammatory Role of Vascular Endothelial Growth Factor in the Pathogenesis of Rheumatoid Arthritis: Prospects for Therapeutic Intervention. Mediators of Inflammation 2008, pages 1-6.
Crossref
Crossref
Jeanny B. Aragon-Ching & William L. Dahut. (2008) The Role of Angiogenesis Inhibitors in Prostate Cancer. The Cancer Journal 14:1, pages 20-25.
Crossref
Crossref
Yongping Crawford & Napoleone Ferrara. 2008. Angiogenesis: In Vivo Systems, Part B. Angiogenesis: In Vivo Systems, Part B
125
139
.
Don L. Gibbons, Robert A. Wolff & Gauri Varadhachary. 2008. Targeted Cancer Therapy. Targeted Cancer Therapy
271
287
.
Zoltán Szekanecz & Alisa E Koch. (2007) Mechanisms of Disease: angiogenesis in inflammatory diseases. Nature Clinical Practice Rheumatology 3:11, pages 635-643.
Crossref
Crossref
Xue-peng CHEN, Hong QIAN, June-jie WU, Xian-wei MA, Ze-xu GU, Hai-yan SUN, Yin-zhong DUAN & Zuo-lin JIN. (2007) Expression of vascular endothelial growth factor in cultured human dental follicle cells and its biological roles. Acta Pharmacologica Sinica 28:7, pages 985-993.
Crossref
Crossref
Alexander S. Kiselyov, Daniel Milligan & Xiaohu Ouyang. (2007) Novel inhibitors of VEGF receptors-1 and -2 based on azole-5-carboxamide templates. Bioorganic & Medicinal Chemistry Letters 17:13, pages 3550-3557.
Crossref
Crossref
Alexander S. Kiselyov, Evgueni Piatnitski, Daniel Milligan & Xiaohu Ouyang. (2007) 1H-1,2,4-Triazol-3-yl-anilines: Novel Potent Inhibitors of Vascular Endothelial Growth Factor Receptors 1 and 2. Chemical Biology & Drug Design 69:5, pages 331-337.
Crossref
Crossref